Pluristem Therapeutics Inc. (Nasdaq: PSTI) announced that a reduction of fibrotic processes has been demonstrated in preclinical and in in-vitro ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE